These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10839656)

  • 1. Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate.
    Fraternale A; Casabianca A; Tonelli A; Vallanti G; Chiarantini L; Brandi G; Celeste AG; Magnani M
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):209-20. PubMed ID: 10839656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS.
    Fraternale A; Tonelli A; Casabianca A; Chiarantini L; Schiavano GF; Celeste AG; Magnani M
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):107-13. PubMed ID: 10737424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels.
    Fraternale A; Casabianca A; Orlandi C; Chiarantini L; Brandi G; Silvestri G; Magnani M
    Virology; 2002 Oct; 302(2):354-62. PubMed ID: 12441079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine AIDS by a new azidothymidine homodinucleotide.
    Magnani M; Casabianca A; Fraternale A; Brandi G; Chiarantini L; Benatti U; Scarfì S; Millo E; De Flora A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):189-95. PubMed ID: 9495216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate.
    Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of macrophage protection in the development of murine AIDS.
    Fraternale A; Tonelli A; Casabianca A; Vallanti G; Chiarantini L; Schiavano GF; Benatti U; De Flora A; Magnani M
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):81-9. PubMed ID: 10360798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS.
    Magnani M; Fraternale A; Casabianca A; Schiavano GF; Chiarantini L; Palamara AT; Ciriolo MR; Rotilio G; Garaci E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1093-9. PubMed ID: 9282814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug combinations for the treatment of murine AIDS and macrophage protection.
    Fraternale A; Casabianca A; Tonelli A; Chiarantini L; Brandi G; Magnani M
    Eur J Clin Invest; 2001 Mar; 31(3):248-52. PubMed ID: 11264653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS.
    Casabianca A; Vallanti G; Magnani M
    J Clin Microbiol; 1998 Aug; 36(8):2371-4. PubMed ID: 9666028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model.
    Fraternale A; Casabianca A; Orlandi C; Cerasi A; Chiarantini L; Brandi G; Magnani M
    Antiviral Res; 2002 Dec; 56(3):263-72. PubMed ID: 12406509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine.
    Rossi L; Serafini S; Franchetti P; Casabianca A; Orlandi C; Schiavano GF; Carnevali A; Magnani M
    J Antimicrob Chemother; 2002 Nov; 50(5):639-47. PubMed ID: 12407119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model.
    Basham T; Rios CD; Holdener T; Merigan TC
    J Infect Dis; 1990 May; 161(5):1006-9. PubMed ID: 2157768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of murine AIDS development by (R)-9-(2-phosphonylmethoxypropyl)adenine.
    Suruga Y; Makino M; Okada Y; Tanaka H; De Clercq E; Baba M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):316-22. PubMed ID: 9704936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
    Mayhew CN; Mampuru LJ; Chendil D; Ahmed MM; Phillips JD; Greenberg RN; Elford HL; Gallicchio VS
    Antiviral Res; 2002 Nov; 56(2):167-81. PubMed ID: 12367722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine AIDS by pro-glutathione (GSH) molecules.
    Fraternale A; Paoletti MF; Casabianca A; Orlandi C; Schiavano GF; Chiarantini L; Clayette P; Oiry J; Vogel JU; Cinatl J; Magnani M
    Antiviral Res; 2008 Feb; 77(2):120-7. PubMed ID: 18164447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.
    Clouser CL; Holtz CM; Mullett M; Crankshaw DL; Briggs JE; O'Sullivan MG; Patterson SE; Mansky LM
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1942-8. PubMed ID: 22271861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
    Chow FP; Hamburger AW
    Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression.
    Phillips NC; Skamene E; Tsoukas C
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):959-66. PubMed ID: 1890605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.